Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jack

Showing results (1001-1010 of 1,303) with videos related to

Pageof 131
Sort By:
Neuroimage|March 24, 2015
Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's diseasePrashanthi Vemuri, Matthew L Senjem, Jeffrey L Gunter, et al.
Journal of Clinical and Experimental Neuropsychology|February 20, 2025
Usability of the Mayo Test Drive remote self-administered web-based cognitive screening battery in adults aged 35-100 with and without cognitive impairmentJay S Patel, Teresa J Christianson, Logan T Monahan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2026
Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic changeBrian J Burkett, Heather J Wiste, Derek R Johnson, et al.
Neurobiology of Aging|May 30, 2017
White-matter integrity on DTI and the pathologic staging of Alzheimer's diseaseKejal Kantarci, Melissa E Murray, Christopher G Schwarz, et al.
Neurobiology of Aging|January 17, 2022
<sup>1</sup>H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adultsFirat Kara, James M Joers, Dinesh K Deelchand, et al.
Parkinsonism & Related Disorders|January 22, 2023
Longitudinal clinical decline and baseline predictors in progressive supranuclear palsyCostanza Pavone, Stephen W Weigand, Farwa Ali, et al.
Brain : a Journal of Neurology|January 18, 2015
Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderlyPrashanthi Vemuri, Timothy G Lesnick, Scott A Przybelski, et al.
Dementia and Geriatric Cognitive Disorders|January 12, 2013
Patterns of brain atrophy in clinical variants of frontotemporal lobar degenerationPo H Lu, Mario F Mendez, Grace J Lee, et al.
Acta Neuropathologica|March 25, 2014
TDP-43 is a key player in the clinical features associated with Alzheimer's diseaseKeith A Josephs, Jennifer L Whitwell, Stephen D Weigand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 5, 2016
Defining imaging biomarker cut points for brain aging and Alzheimer's diseaseClifford R Jack, Heather J Wiste, Stephen D Weigand, et al.
Pageof 131

Showing results (1001-1010 of 1,303) with videos related to

Sort By:
Pageof 131
Neuroimage|March 24, 2015
Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's diseasePrashanthi Vemuri, Matthew L Senjem, Jeffrey L Gunter, et al.
Journal of Clinical and Experimental Neuropsychology|February 20, 2025
Usability of the Mayo Test Drive remote self-administered web-based cognitive screening battery in adults aged 35-100 with and without cognitive impairmentJay S Patel, Teresa J Christianson, Logan T Monahan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2026
Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic changeBrian J Burkett, Heather J Wiste, Derek R Johnson, et al.
Neurobiology of Aging|May 30, 2017
White-matter integrity on DTI and the pathologic staging of Alzheimer's diseaseKejal Kantarci, Melissa E Murray, Christopher G Schwarz, et al.
Neurobiology of Aging|January 17, 2022
<sup>1</sup>H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adultsFirat Kara, James M Joers, Dinesh K Deelchand, et al.
Parkinsonism & Related Disorders|January 22, 2023
Longitudinal clinical decline and baseline predictors in progressive supranuclear palsyCostanza Pavone, Stephen W Weigand, Farwa Ali, et al.
Brain : a Journal of Neurology|January 18, 2015
Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderlyPrashanthi Vemuri, Timothy G Lesnick, Scott A Przybelski, et al.
Dementia and Geriatric Cognitive Disorders|January 12, 2013
Patterns of brain atrophy in clinical variants of frontotemporal lobar degenerationPo H Lu, Mario F Mendez, Grace J Lee, et al.
Acta Neuropathologica|March 25, 2014
TDP-43 is a key player in the clinical features associated with Alzheimer's diseaseKeith A Josephs, Jennifer L Whitwell, Stephen D Weigand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 5, 2016
Defining imaging biomarker cut points for brain aging and Alzheimer's diseaseClifford R Jack, Heather J Wiste, Stephen D Weigand, et al.
Pageof 131